Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) Europese Unie - Engels - EMA (European Medicines Agency)

adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)

glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human, immunization, disease outbreaks - vaccines, - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official guidance.,

TRELEGY ELLIPTA 92 55 22 MCG Israël - Engels - Ministry of Health

trelegy ellipta 92 55 22 mcg

glaxo smith kline (israel) ltd - fluticasone furoate; umeclidinium as bromide; vilanterol as trifenatate - powder for inhalation pre-dispensed - vilanterol as trifenatate 22 mcg/inh; umeclidinium as bromide 55 mcg/inh; fluticasone furoate 92 mcg/inh - vilanterol, umeclidinium bromide and fluticasone furoate - asthmatrelegy ellipta 92/55/22 mcg is indicated for the maintenance treatment of asthma in patients aged 18 years and older.trelegy ellipta 92/55/22 mcg should be prescribed for patients who are not adequately controlled on maintenance asthma medication, such as an ics/laba.important limitations of use:trelegy ellipta 92/55/22 mcg is not indicated for the relief of acute asthma.copd (chronic obstructive pulmonary disease)trelegy ellipta 92/55/22 mcg is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting β2-agonist or a combination of a long-acting β2-agonist and a long-acting muscarinic antagonist.

LAMICTAL DISPERSIBLECHEWABLE TABLETS 50 MG Israël - Engels - Ministry of Health

lamictal dispersiblechewable tablets 50 mg

glaxo smith kline (israel) ltd - lamotrigine - dispersible/chewable tablets - lamotrigine 50 mg - lamotrigine - lamotrigine - epilepsy• adults and adolescents aged 13 years and above- adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.- seizures associated with lennox-gastaut syndrome. lamictal is given as adjunctive therapy but may be the initial antiepileptic drug (aed) to start with in lennox-gastaut syndrome.• children and adolescents aged 2 to 12 years- adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome.- monotherapy of typical absence seizures.bipolar disorder• adults aged 18 years and above- prevention of depressive episodes in patients with bipolar i disorder who experience predominantly depressive episodes (see section 5.1).lamictal is not indicated for the acute treatment of manic or depressive episodes.

IMITREX TABLETS 100 MG Israël - Engels - Ministry of Health

imitrex tablets 100 mg

glaxo smith kline (israel) ltd - sumatriptan as succinate - film coated tablets - sumatriptan as succinate 100 mg - sumatriptan - sumatriptan - imitrex tablets are indicated for the acute relief of migraine attacks, with or without aura. imitrex should only be used where there is a clear diagnosis of migraine.

IMITREX TABLETS 50 MG Israël - Engels - Ministry of Health

imitrex tablets 50 mg

glaxo smith kline (israel) ltd - sumatriptan as succinate - film coated tablets - sumatriptan as succinate 50 mg - sumatriptan - sumatriptan - imitrex tablets are indicated for the acute relief of migraine attacks, with or without aura. imitrex should only be used where there is a clear diagnosis of migraine.

NARAMIG TABLETS 2.5 MG Israël - Engels - Ministry of Health

naramig tablets 2.5 mg

glaxo smith kline (israel) ltd - naratriptan as hydrochloride - film coated tablets - naratriptan as hydrochloride 2.5 mg - naratriptan - naratriptan - naramig tablets are indicated for the acute treatment of migraine attacks with or without aura.

Relenza 5mg/dose, inhalation powder, pre-dispensed Ierland - Engels - HPRA (Health Products Regulatory Authority)

relenza 5mg/dose, inhalation powder, pre-dispensed

glaxosmithkline (ireland) limited - zanamivir - inhalation powder, pre-dispensed - 5 milligram(s)/dose - zanamivir

Bactroban 2% ointment Verenigd Koninkrijk - Engels - MHRA (Medicines & Healthcare Products Regulatory Agency)

bactroban 2% ointment

glaxosmithkline uk ltd - mupirocin - cutaneous ointment - 20mg/1gram

Duac Once Daily 10mg/g + 50mg/g Gel Ierland - Engels - HPRA (Health Products Regulatory Authority)

duac once daily 10mg/g + 50mg/g gel

glaxosmithkline (ireland) limited - clindamycin phosphate; benzoyl peroxide hydrous - gel - 10mg/g + 50 milligram(s)/gram - antiinfectives for treatment of acne; clindamycin, combinations

Augmentin Intravenous 1000mg/200mg powder for solution for injection or infusion Ierland - Engels - HPRA (Health Products Regulatory Authority)

augmentin intravenous 1000mg/200mg powder for solution for injection or infusion

glaxosmithkline (ireland) limited - amoxicillin; clavulanic acid - powder for solution for injection/infusion - 1000 mg/200 milligram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; amoxicillin and enzyme inhibitor